340B Drug Pricing Program Contributes to Rising Healthcare Costs and Is Ripe for Reform
The U.S. House Energy & Commerce Committee's Health Subcommittee today will host the third hearing in its health care affordability series, specifically examining the role providers and hospitals play in shaping the cost of care for Americans.
While the hearing will likely examine numerous issues, there is none more ripe for reform than the flawed 340B drug pricing program.
Originally enacted to help eligible safety-net providers buy medicines at steep discounts and pass the savings on to lower-income and vulnerable patients, the program has ballooned as a revenue stream for many participating hospitals and contract pharmacy chains.
As the size and complexity of the 340B program has expanded, participating hospitals and contract pharmacies have instead used the program to increase…[more]
Last week’s video of a hatchet-wielding maniac terrorizing patrons in a New York City McDonald’s deepened the sense that it’s the 1970s again in New York.
The footage resonates even more deeply for symbolizing an increasing sense of random lawlessness across America, particularly after the assailant was released without bail under New York’s “bail reform” laws.
Accordingly, a man who should remain jailed under any reasonable standard was instead unleashed upon the public without spending a single day behind bars.
In a similarly…
